Evaluating Simvastatin's Potential Role in Therapy

Summary

Evaluating Simvastatin's Potential Role in Therapy is a clinical trial^[1].

Key Facts

• Evaluating Simvastatin's Potential Role in Therapy is in the country of United States^[2].
• Evaluating Simvastatin's Potential Role in Therapy's instance of is recorded as clinical trial^[3].
• Evaluating Simvastatin's Potential Role in Therapy's start time is recorded as +2005-02-28T00:00:00Z^[4].
• Evaluating Simvastatin's Potential Role in Therapy's end time is recorded as +2009-06-30T00:00:00Z^[5].
• Evaluating Simvastatin's Potential Role in Therapy's number of participants is recorded as {'unit': '1', 'amount': '+103'}^[6].
• Evaluating Simvastatin's Potential Role in Therapy's title is recorded as Effect of Statins on Pathobiology of Alzheimer's Disease^[7].
• Evaluating Simvastatin's Potential Role in Therapy's short name is recorded as ESPRIT^[8].
• Evaluating Simvastatin's Potential Role in Therapy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+35'}^[9].
• Evaluating Simvastatin's Potential Role in Therapy's ClinicalTrials.gov ID is recorded as NCT00486044^[10].
• Evaluating Simvastatin's Potential Role in Therapy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+69'}^[11].
• Evaluating Simvastatin's Potential Role in Therapy's research intervention is recorded as simvastatin/sitagliptin^[12].
• Evaluating Simvastatin's Potential Role in Therapy's clinical trial phase is recorded as phase II clinical trial^[13].
• Evaluating Simvastatin's Potential Role in Therapy's research site is recorded as University of Wisconsin–Madison^[14].
• Evaluating Simvastatin's Potential Role in Therapy's research subject recruitment status is recorded as completed^[15].
• Evaluating Simvastatin's Potential Role in Therapy's study type is recorded as interventional study^[16].